A Potential Novel COVID-19 Vaccine With RBD-HR1/HR2 Hexamer Structure
H. Liu, X. Gao, G. Wang, J. Zhang, J. Zhou, T. Wei, Y. Zhang, Y. Liu, J. Piao, Q. Zhang, Y. Wang, X. Ma, X. Zhu, Y. Rao, W. Xia, , W. Zhang
This paper introduces a novel COVID-19 vaccine based on a RBD-HR1/HR2 hexamer structure that induces high neutralizing antibody titers and alternative antibodies targeting the HR1 region in mice.
bioRxiv · Oct 28, 2021 · PreprintBiochemistry